PMID- 37173568 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231113 IS - 2198-6576 (Print) IS - 2198-6584 (Electronic) IS - 2198-6576 (Linking) VI - 10 IP - 4 DP - 2023 Aug TI - Effectiveness of Shiatsu on Fatigue in Patients with Axial Spondyloarthritis: Protocol for a Randomized Cross-Over Pilot Study. PG - 1107-1117 LID - 10.1007/s40744-023-00558-w [doi] AB - INTRODUCTION: Spondyloarthritis (SpA) is a serious chronic inflammatory rheumatism implying different painful and crippling symptoms that require a multidisciplinary approach for the patient. Fatigue is one of the less well treated symptoms, even if its repercussion on everyday life is noticeable. Shiatsu is a Japanese preventive and well-being therapy that aims to promote better health. However, the effectiveness of shiatsu in SpA-associated fatigue has never been studied yet in a randomized study. METHODS AND ANALYSIS: We describe the design of SFASPA (Etude pilote randomisee en cross-over evaluant l'efficacite du Shiatsu sur la FAtigue des patients atteints de SPondyloarthrite Axiale), a single-center, randomized controlled cross-over trial with allocation of patients according to a ratio (1:1) evaluating the effectiveness of shiatsu in SpA-associated fatigue. The sponsor is the Regional Hospital of Orleans, France. The two groups of 60 patients each will receive three "active" shiatsu and three sham shiatsu treatments (120 patients, 720 shiatsu). The wash-out period between the active and the sham shiatsu treatments is 4 months. PLANNED OUTCOMES: The primary outcome is the percentage of patients responding to the FACIT-fatigue score. A response to fatigue is defined as an improvement, i.e., an increase of >/= 4 points in the FACIT-fatigue score, which corresponds to the "minimum clinically important difference" (MCID). Differences in the evolution of activity and impact of the SpA will be assessed on several secondary outcomes. An important aim of this study is also to gather material for further trials with higher proof of evidence. TRIAL REGISTRATION: NCT05433168, date of registration, June 21st, 2022 (clinicaltrials.gov). CI - (c) 2023. The Author(s). FAU - Bernardinelli, Nathalie AU - Bernardinelli N AD - Syndicat des Professionnels de Shiatsu, Shiatsu Specialist, Poissy, France. FAU - Valery, Antoine AU - Valery A AD - Department of Medical Informatics and Statistics, Regional Hospital of Orleans, Orleans, France. FAU - Barrault, Denys AU - Barrault D AD - IPROS, University Hospital Center of Orleans, Orleans, France. FAU - Dorland, Jean-Marc AU - Dorland JM AD - Shiatsu Specialist, Orleans, France. FAU - Palut, Patricia AU - Palut P AD - IPROS, University Hospital Center of Orleans, Orleans, France. FAU - Toumi, Hechmi AU - Toumi H AD - Department of Rheumatology, University Hospital Center of Orleans, Orleans, France. AD - Translational Medicine Research Platform, PRIMMO, University Hospital Center of Orleans, Orleans, France. AD - Regional Hospital of Orleans, 14 Avenue de L'Hopital, 45067, Orleans Cedex 2, France. FAU - Lespessailles, Eric AU - Lespessailles E AUID- ORCID: 0000-0003-1009-8518 AD - Department of Rheumatology, University Hospital Center of Orleans, Orleans, France. eric.lespessailles@chr-orleans.fr. AD - Translational Medicine Research Platform, PRIMMO, University Hospital Center of Orleans, Orleans, France. eric.lespessailles@chr-orleans.fr. AD - Regional Hospital of Orleans, 14 Avenue de L'Hopital, 45067, Orleans Cedex 2, France. eric.lespessailles@chr-orleans.fr. LA - eng SI - ClinicalTrials.gov/NCT05433168 PT - Journal Article DEP - 20230512 PL - England TA - Rheumatol Ther JT - Rheumatology and therapy JID - 101674543 PMC - PMC10326191 OTO - NOTNLM OT - Cross-over OT - Fatigue OT - Randomized controlled trial OT - Shiatsu OT - Spondyloarthritis COIS- Nathalie Bernardinelli, Antoine Valery, Denys Barrault, Jean-Marc Dorland, Patricia Palut, Hechmi Toumi, Eric Lespessailles have nothing to disclose Denys Barrault and Patricia Palut are now affiliated with IPROS, University Hospital Center of Orleans, Orleans, France. EDAT- 2023/05/13 15:13 MHDA- 2023/05/13 15:14 PMCR- 2023/05/12 CRDT- 2023/05/12 23:27 PHST- 2023/03/17 00:00 [received] PHST- 2023/04/24 00:00 [accepted] PHST- 2023/05/13 15:14 [medline] PHST- 2023/05/13 15:13 [pubmed] PHST- 2023/05/12 23:27 [entrez] PHST- 2023/05/12 00:00 [pmc-release] AID - 10.1007/s40744-023-00558-w [pii] AID - 558 [pii] AID - 10.1007/s40744-023-00558-w [doi] PST - ppublish SO - Rheumatol Ther. 2023 Aug;10(4):1107-1117. doi: 10.1007/s40744-023-00558-w. Epub 2023 May 12.